Literature DB >> 7528991

Capillary perfusion during ischemia-reperfusion in subcutaneous connective tissue and skin muscle.

B Friesenecker1, A G Tsai, M Instaglietta.   

Abstract

Ischemia-reperfusion injury was investigated in terms of functional capillary density (FCD), capillary red blood cell velocity (cRBCv), and arteriolar and venular diameter after 4-h ischemia in the unanesthetized hamster skin-fold preparation. Animals in group 1 were studied by transillumination. Group 2 received a bolus injection of fluorescein isothiocyanate (FITC)-dextran (mol wt 150,000) and was studied by transillumination (zone 1) and epi-illumination (zone 2). In group 1, FCD decreased after ischemia (92% of baseline, 30 min), returning to control up to 24 h. cRBCv increased after reperfusion, being 175% of baseline at 24 h. Arterioles and venules dilated for 24 h after reperfusion. In group 2/zone 2, FCD progressively decreased to 11% of control, arteriolar dilation was inhibited, and cRBCv increased 30 min and 2 h after reperfusion. Tissue perfusion index (FCD x cRBCv) increased 158% in group 1 at 24 h, did not change in group 2/zone 1, and was 9% of control at 24 h in group 2/zone 2 (P < or = 0.05). We conclude that increased perfusion is a normal reaction to ischemia-reperfusion injury in this model, and previously observed capillary no reflow is due to FITC-dextran phototoxicity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7528991     DOI: 10.1152/ajpheart.1994.267.6.H2204

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Characterization and efficacy of PKH26 as a probe to study the replication history of the human hematopoietic KG1a progenitor cell line.

Authors:  Gyun Min Lee; Stephen S Fong; Duk Jae Oh; Karl Francis; Bernhard O Palsson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-02       Impact factor: 2.416

2.  The use of diagnostic frequency continuous ultrasound to improve microcirculatory function after ischemia-reperfusion injury.

Authors:  C Makena Hightower; Marcos Intaglietta
Journal:  Microcirculation       Date:  2007-08       Impact factor: 2.628

3.  The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury.

Authors:  Pedro Cabrales; Scott Caroen; Arnold Oronsky; Corey Carter; Jane Trepel; Thomas Summers; Tony Reid; Neil Oronsky; Michelle Lybeck; Bryan Oronsky
Journal:  Expert Rev Hematol       Date:  2017-05-22       Impact factor: 2.929

4.  Plasma expander and blood storage effects on capillary perfusion in transfusion after hemorrhage.

Authors:  C Makena Hightower; Beatriz Y Salazar Vázquez; Pedro Cabrales; Amy G Tsai; Seetharama A Acharya; Marcos Intaglietta
Journal:  Transfusion       Date:  2012-05-03       Impact factor: 3.157

5.  Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock.

Authors:  Beatriz Y Salazar Vázquez; C Makena Hightower; Judith Martini; Catalina Messmer; Barbara Frienesenecker; Pedro Corbels; Amy G Tsai; Marcos Intaglietta
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

6.  Early iNOS impairment and late eNOS enhancement during reperfusion following 2.49 MHz continuous ultrasound exposure after ischemia.

Authors:  C Makena Hightower; Marcos Intaglietta
Journal:  Ultrason Sonochem       Date:  2008-05-24       Impact factor: 7.491

7.  PEG-albumin plasma expansion increases expression of MCP-1 evidencing increased circulatory wall shear stress: an experimental study.

Authors:  C Makena Hightower; Beatriz Y Salazar Vázquez; Seetharama A Acharya; Shankar Subramaniam; Marcos Intaglietta
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 8.  Pathophysiological Mechanisms of Chronic Venous Disease and Implications for Venoactive Drug Therapy.

Authors:  Armando Mansilha; Joel Sousa
Journal:  Int J Mol Sci       Date:  2018-06-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.